Selective IgA deficiency disease
MONDO:0001341A dysgammaglobulinemia characterized by low or undetectable serum levels of immunoglobulin class A (IgA). It is the most common primary antibody deficiency. It may be inherited or the reversible sequela of infection or certain drugs. It may be caused by decreased or inefficient class-switching from progenitor B cells without any corresponding decreases in the other isotypes. Though affected persons may be asymptomatic, low levels of IgA will reduce the immune system's ability to combat infection where IgA is normally secreted, at mucosal surfaces. Selective IgA deficiency is seen in greater proportion among patients with autoimmune disorders.
Also known as: SIgAD, immunoglobulin A deficiency, selective IgA immunodeficiency, IgA deficiencies, deficiencies, IgA, deficiency, IgA, immunoglobulin alpha deficiency
43 clinical trials for this condition and its sub-types, 2 tagged with Selective IgA deficiency disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Selective IgA deficiency disease
-
IgAD1 0 trials
-
Immunoglobulin A deficiency 2 0 trials
-
Secretory component deficiency 0 trials
-
App-Based exercise may boost immune health in antibody deficiency
Symptom relief Recruiting nowThis study tests whether a 12-week, app-guided exercise program is safe and practical for adults with primary antibody deficiencies—conditions where the immune system struggles to fight infections. Researchers will track how many people join and finish the program, how often they…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Scientists launch major study to unravel mysteries of rare immune diseases
Knowledge-focused Recruiting nowThis study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity. Researchers will observe up to 500 patients over time using blood tests, imaging, and other exams. The goal is to find better ways to diagnos…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC